Effect of Sweet almond on ADHD

Effectiveness of Sweet almond syrup, Iranian Traditional Medicine product, compared with methylphenidate for Attention-Deficit/Hyperactivity Disorder in children: triple-blind randomized Clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015050922165N1

Enrollment

Registered

2015-07-14

Start date

2015-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-Deficit/Hyperactivity Disorder. Disturbance of activity and attention

Interventions

Intervention 1: Intervention Group: Sweet almond syrup 5 cc/TDS and an ineffective tablet as placebo for 8 weeks. Intervention 2: Control Group: Ritalin 1mg/kg/day and an ineffective syrup as placebo

Treatment - Other

Placebo

Intervention Group: Sweet almond syrup 5 cc/TDS and an ineffective tablet as placebo for 8 weeks

Control Group: Ritalin 1mg/kg/day and an ineffective syrup as placebo 5cc/TDS for 8 weeks

Eligibility

Sex/Gender

All

Age

6 Years to 14 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age 6 to 14 years; Combined subtype ADHD diagnosis by a psychiatrist; Obtain written informed consent from each patient's parent or guardian; No mental retardation (I.Q.>70); Non use of other Complementary and Alternative Medicine methods; No any significant chronic medical condition including cardiovascular disease, GI disorders, seizures; No other psychiatric disorder such as schizophrenia; No organic brain disorder; No clear developmental disorders and Malnutrition; no recent treatment with psychotherapic drugs; Not clinically current abuse or dependence on drugs within 6 months; New diagnoses of disorder and No other drug use; Not required behavior Therapy; No sensitivity to sweet almond and its products; Non-concurrent use of other products containing almonds (Nuts, nougat) Exclusion criteria: Symptoms of sensitivity to sweet almond; Intolerance sweet almond syrup; Complications increase in moisture in the body; Dissatisfaction of parents or patient; The risk of other mental illness that requires treatment during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
ADHD severity. Timepoint: weeks 2, 4, 6 and 8 after starting the drug. Method of measurement: Standard Teacher and Parent ADHD rating scale.	—

Secondary

Measure	Time frame
Adverse effect of sweet almond syrup (skin & respiratory sensitivity ...). Timepoint: weeks 2, 4, 6 and 8 after starting the drug. Method of measurement: Questionnaire.;Adverse effect of Ritalin (headache, abdominal pain, nausea, ...). Timepoint: weeks 2, 4, 6 and 8 after starting the drug. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMonireh sadat Motahari fard

Tehran University of Medical Sciences

m-motaharifard@razi.tums.irmonirehmotahari@yahoo.com+98 21 5563 9724

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026